Dec 22 2024
Despite marijuana remaining a Schedule I drug on the federal level, 2024 has been a huge year for marijuana research. As marijuana moves closer to being rescheduled to Schedule III, the potential for easier and more comprehensive research on marijuana and its compounds appears to be on the horizon. While this change has not yet …
Dec 19 2024
In a new study published in the Journal of Southeast Asian Orthopaedics, marijuana oil significantly reduced knee pain and improved quality of life in subjects suffering from treatment-resistant osteoarthritis. Conducted by researchers from Srisangworn Hospital in Thailand, the study evaluated the “effectiveness of cannabis oil in treating severe knee osteoarthritis in patients awaiting total knee …
Dec 19 2024
Cannabidiol (CBD) has shown promising results in supporting dental stem cell regeneration and combating inflammation, according to a study by researchers from Chulalongkorn University in Thailand and the University of Hong Kong. The study, published in the International Endodontic Journal, investigated how CBD impacts human dental pulp stem cells (hDPSCs) under both normal and inflamed …
Dec 19 2024
A new study suggests that cannabidiol (CBD) may offer a promising approach to controlling metastatic castration-resistant prostate cancer (mCRPC), an aggressive form of prostate cancer. Researchers from the University of Louisiana and Mansoura University conducted the study, published in ACS Pharmacology & Translational Science and published online by the U.S. National Library of Medicine. Metastatic …
Dec 19 2024
A study published in the peer reviewed journal Molecular Psychiatry has found that psilocybin-assisted therapy significantly improves emotional empathy in patients with major depression. The study, titled Psilocybin increases emotional empathy in patients with major depression, explored the enduring effects of psilocybin on social cognition, using a randomized, placebo-controlled design involving 51 depressed patients. Participants …
Dec 18 2024
Patients with inflammatory bowel disease experience significant improvements in quality of life after using cannabis-based medicinal products, according to a study published in Expert Review of Gastroenterology & Hepatology. “Treatments for inflammatory bowel disease (IBD) remain limited, and cannabis-based medicinal products (CBMPs) provide promise in addressing inflammation and pain”, states the study, conducted by researchers …
Dec 17 2024
A new study published in the International Journal of Molecular Sciences highlights the potential of phytocannabinoid-based formulations in skincare. “Recent advancements have highlighted the potential of cannabis and its phytocannabinoids (pCBs) in skin health applications”, begins the study’s abstract. “These compounds, through their interaction with the endocannabinoid system (ECS), show promise for skin health products. …
Dec 17 2024
Federally funded survey data from the University of Michigan reveals that teen marijuana use has dropped significantly over the past decade, reaching historic lows. The annual Monitoring the Future report finds that cannabis use among young people is at a 30-year low, consistent with trends previously reported by the Centers for Disease Control and Prevention …
Dec 16 2024
A study published in JAMA Network Open found that cannabidiol (CBD) may alleviate anxiety in women with advanced breast cancer. The randomized, double-masked clinical trial was conducted by researchers from the Dana-Farber Cancer Institute, Harvard Medical School, New York Medical College, and Cambridge. The study included 50 participants aged 18 and older with baseline clinical …
Dec 16 2024
Mind Medicine Inc., a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that the first patient has been dosed in its Phase 3 Voyage study of MM120 ODT, a pharmaceutically optimized form of lysergide D-tartrate (LSD) for the treatment of GAD. Voyage is the first of two Phase 3 …
